“Versavo 400 Solution for Infusion” has been added to your cart. View cart
Hardshot 100Mg Sildenafil Citrare100Mg BpTablets
$13.18 – $39.53Price range: $13.18 through $39.53
Chlorquinon Phosphate Tablets 250Mg
$14.38 – $43.13Price range: $14.38 through $43.13
Available Options
| Tablets | Price | Description | Quantity | |
|---|---|---|---|---|
| 100 Tablets | $0.14/Piece | |||
| 200 Tablets | $0.14/Piece | |||
| 300 Tablets | $0.14/Piece |
Chloroquine Phosphate is the phosphate salt of chloroquine, a quinoline compound with anti malarial and anti-inflammatory properties. Chloroquine is the most widely used drug against malaria, except for those cases caused by chloroquine resistant Plasmodium falciparum
SKU:
N/A
Categories: Arthritis, Generic & Branded Medicines Manufacturing, Generic Arthritis
Tag: Arthritis
Description
| Packaging Size | 1*10 tablet |
| Brand | lariago |
| Manufacturer | ipca |
| Composition | Chloroquine Phosphate |
| Treatment | Antimalarial drugs |
| Prescription/Nonprescription | Prescription |
| Form | Tablet |
| Country of Origin | Made in India |
Additional information
| Tablets |
100 Tablets ,200 Tablets ,300 Tablets |
|---|
Reviews (0)
Be the first to review “Chlorquinon Phosphate Tablets 250Mg” Cancel reply
Related products
Alphalan 5 Mg (Melphalan)
Rated 0 out of 5
In stock
$239.00 – $855.00Price range: $239.00 through $855.00
Select options
This product has multiple variants. The options may be chosen on the product page
Anaridex 1 Mg (Anastrozole)
Rated 0 out of 5
In stock
$43.80 – $203.80Price range: $43.80 through $203.80
Select options
This product has multiple variants. The options may be chosen on the product page
AVP Anu Thailam Nasal Drops
Rated 0 out of 5
In stock
Duolin Inhaler
Rated 0 out of 5
In stock
Iverheal 3Mg
Rated 0 out of 5
In stock
$19.00 – $55.00Price range: $19.00 through $55.00
Select options
This product has multiple variants. The options may be chosen on the product page
Systane Hydration Lubricant Eye Drop
Rated 0 out of 5
In stock

Reviews
There are no reviews yet.